Merck: Vioxx Litigation Strategy Is Working

Law360, New York (December 14, 2006, 12:00 AM EST) -- Merck & Co. Inc. has notched another win in a personal injury suit stemming form the use of the painkiller Vioxx, a development the company is touting as a vindication of its strategy to tackle thousands of Vioxx product liability claims individually. But an attorney for the plaintiff says it’s too early for Merck to be crowing.

“We think that our record in the court shows that our strategy is the right one,” said Kent Jarrell, a spokesman for Merck’s outside counsel, going on to point...
To view the full article, register now.